The “Sputnik” vaccine competes with Pfizer and Moderna … at a price of $ 20



[ad_1]

The official account of the Russian vaccine “Sputnik 7” on Twitter, today Tuesday, November 24, released the results of the studies carried out on the vaccine, 42 days after the first dose was administered. The effectiveness of the vaccine was 95 percent, as long as the person received the second dose of the vaccine.

The results revealed that the effectiveness of the vaccine had reached 91.4 percent on day 28 of receiving the first dose and on the seventh day of receiving the second dose, but reached 95 percent on day 42, after the first dose. and on day 21 after the second dose. It appeared that the volunteers formed a stable immune response.

A statement issued by the center, the Russian Ministry of Health and the Sovereign Fund of Russia, the participants of the vaccine, in which the Gamalia Research Center in Moscow works, indicated that “these are preliminary results of experiments on volunteers 42 days after the injection of the first dose.

Regarding the price of the vaccine, the official page of the vaccine on “Twitter” confirmed that the price of the vaccine will not exceed $ 20 per person in global markets, but it will be available free of charge to Russian citizens.

The Russian Fund for Direct Investment announced that the price of the vaccine “Sputnik 7” would be cheaper than that of the American vaccines. The price of the Russian vaccine will be released later, indicating that the price of the vaccine developed by the American pharmaceutical company “Pfizer” and “Moderna” of the Americas, reached 25 and 37 dollars, respectively.




[ad_2]